ArticleThe New phytologist2026
Phytosulfokine signalling blocks mycotoxin toxicity in Arabidopsis and mediates suppression of cell death activated by bacterial microbe-associated molecular patterns.
Article in The New phytologist, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Fumonisin B1 (FB1) is a mycotoxin that disrupts ceramide biosynthesis and kills plants. Prior activation with bacterial microbe-associated molecular patterns (MAMPs), such as components of bacterial flagella, effectively suppresses FB1-induced cell death. The molecular basis of this defence against mycotoxin toxicity is poorly understood. Analysis of extracellular peptide receptors provided initial circumstantial evidence linking phytosulfokine (PSK) signalling with Arabidopsis thaliana responses to FB1. We used synthetic PSK peptides and quantitative proteomics to investigate this link and established the basis for peptide-induced Arabidopsis immunity to FB1. Exogenous PSK fully protected Arabidopsis plants from FB1 toxicity in wild-type plants, but not in loss-of-function mutants lacking PSK RECEPTOR 1 (PSKR1) or its co-receptor BRASSINOSTEROID INSENSITIVE 1-ASSOCIATED RECEPTOR KINASE 1 (BAK1). Mutants lacking the precursor PSK-processing subtilase (SBT3.8) enzyme were more sensitive to FB1. The partial flagellin peptide flg22, which activates innate immunity to block FB1 toxicity in wild-type plants, failed to rescue pskr1 mutants, indicating that PSK signalling functions downstream of flg22. Proteomic analysis revealed Calvin cycle downregulation by FB1, while co-application of the toxin with PSK increased Calvin cycle capacity. Our study reveals that the mechanism of disabling mycotoxin toxicity by MAMPs is activation of PSK signalling and stimulation of the photosynthetic machinery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.